Brivaracetam Tablet, Film Coated
FDA Label NDC 70771-1757

The following Structured Product Label (SPL) was submitted to the FDA by Zydus Lifesciences Limited for the product Brivaracetam (NDC 70771-1757). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding package label.principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Package Label.Principal Display Panel

NDC 70771-1754-6

Brivaracetam tablets, 10 mg - CV

60 Tablets

Rx only

10 mg (Efe071ad F406 4c67 9c8e 24df2e7f20c7 01)

NDC 70771-1755-6

Brivaracetam tablets, 25 mg - CV

60 Tablets

Rx only

25 mg (Efe071ad F406 4c67 9c8e 24df2e7f20c7 02)

NDC 70771-1756-6

Brivaracetam tablets, 50 mg - CV

60 Tablets

Rx only

50 mg (Efe071ad F406 4c67 9c8e 24df2e7f20c7 03)

NDC 70771-1757-6

Brivaracetam tablets, 75 mg - CV

60 Tablets

Rx only

75 mg (Efe071ad F406 4c67 9c8e 24df2e7f20c7 04)

NDC 70771-1758-6

Brivaracetam tablets, 100 mg - CV

60 Tablets

Rx only

100 mg (Efe071ad F406 4c67 9c8e 24df2e7f20c7 05)

* Please review the disclaimer below.